Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Sphingomyelins and ceramides: possible biomarkers for dementia?51
Genetic variation in apolipoprotein A-V in hypertriglyceridemia50
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism49
Editorial introductions47
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review39
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?35
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease33
ANGPTL4: a new mode in the regulation of intravascular lipolysis33
Alveolar macrophages: guardians of the alveolar lipid galaxy30
Familial hypercholesterolemia in children and the importance of early treatment28
Implementation science and genetic testing for familial hypercholesterolemia28
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?28
Oxidized LDL receptors: a recent update27
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1925
Exosomes and lipid metabolism in metabolic and cardiovascular disorders24
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases22
Editorial introductions22
Lipid metabolism during pregnancy: consequences for mother and child22
Nonalcoholic fatty liver disease: an update20
Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations18
Nutrition and its impact on cardiovascular disease17
The current state of apolipoprotein E in dyslipidemia16
Lipid effects of glucagon-like peptide 1 receptor analogs15
Genetic determinants of pancreatitis risk in hypertriglyceridemia15
A new SPRING in lipid metabolism15
Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia15
From clinical development to real-world outcomes with inclisiran14
Familial hypercholesterolemia in pregnancy14
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion13
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?13
The need for national and international registries of patients with elevated lipoprotein(a)13
APOE and familial hypercholesterolemia13
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives13
Can small dense LDL cholesterol be estimated from the lipid profile?12
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent12
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?11
Cardiomyocytes, sphingolipids and cardio myotoxicity11
Newborn screening for lipid disorders11
Editorial introductions10
Distinct roles of size-defined HDL subpopulations in cardiovascular disease10
Recent dynamic studies of the metabolism of atherogenic lipoproteins: elucidating the mode of action of new therapies10
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis10
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease10
Pregnancy, cardiovascular health, and microchimerism9
Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia9
Genetic testing for familial hypercholesterolemia9
Preprint servers in lipidology: current status and future role9
Strategies for management of patients with elevated lipoprotein(a)9
Clinical associations between exercise and lipoproteins9
Metabolic regulation of macrophage proliferation and function in atherosclerosis8
Altered cardiovascular risk pattern of LDL cholesterol in older adults8
Genotype–phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia7
Assessment of cardiovascular disease risk: a 2023 update7
LDL receptor-related protein 1 and its interacting partners in tissue homeostasis7
Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review7
Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment7
The pathophysiology of excess plasma-free cholesterol7
Clonal hematopoiesis of indeterminate potential and the evolutionary lottery in chromosome 2: does that make human atherosclerosis special?7
The feedback cycles between glucose, amino acids and lipids and alpha cell secretion and their role in metabolic fatty liver disease7
Prevention of cardiometabolic diseases through dietary modifications7
0.054783821105957